Patients with Hepatitis B: Medical Comorbidities That Can Impact Treatment and Prompt the Provider to Switch
This activity offers CE credit for:%>
- Pharmacists (ACPE)
All other clinicians will receive a Certificate of Attendance stating this activity was certified for AMA PRA Category 1 Credit™
Credit Expiration Date:
Tuesday, September 27, 2022
Note: Credit Is No Longer Available
|Kimberly A. Forde, MD, PhD, MHS (Moderator)
Associate Professor of Medicine
Section of Hepatology, Department of Medicine
Temple University Hospital, Lewis Katz School of Medicine
|Christina M. Madison, PharmD, FCCP, AAHIVP
Founder and CEO, The Public Health Pharmacist, PLLC
Associate Professor of Pharmacy Practice
Roseman University of Health Sciences, College of Pharmacy
Las Vegas, NV
As a result of often-delayed diagnosis and treatment, patients with Chronic Hepatitis B (CHB) are presenting at an older age and with more liver and non-liver comorbidities that can further complicate treatment. Keeping a watchful eye on patients' use of over-the-counter medications, supplements, and prescription medications for comorbid disorders that may interact with their HBV antiviral treatment is imperative.
This CME Outfitters webcast focuses on how pharmacists can partner with patients to help them to better understand their HBV, as well as best practices for communicating and collaborating with health care professionals about patients' HBV treatment plans, and how they might be impacted by medical comorbidities, in order to optimize patient outcomes.
At the end of this CE activity, participants should be able to:
- Partner with patients with HBV and their HCPs to support therapeutic decision-making in the presence of renal and bone comorbidities.
Supported by an educational grant from Gilead Sciences, Inc.
CPE Credit (Pharmacists):
CME Outfitters, LLC, is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. .5 contact hours (0.05 CEUs) Universal Activity Number: Enduring: JA0007185-0000-21-159-H01-P
It is the policy of CME Outfitters, LLC, to ensure independence, balance, objectivity, and scientific rigor and integrity in all of their CE activities. Faculty must disclose to the participants any relationships with commercial companies whose products or devices may be mentioned in faculty presentations, or with the commercial supporter of this CE activity. CME Outfitters, LLC, has evaluated, identified, and attempted to resolve any potential conflicts of interest through a rigorous content validation procedure, use of evidence-based data/research, and a multidisciplinary peer review process. The following information is for participant information only. It is not assumed that these relationships will have a negative impact on the presentations.
Dr. Forde has no disclosures to report.
Dr. Madison reports that she is on the speakers bureau for Gilead Sciences, Inc. and Janssen Therapeutics.
Mae Ochoa, RPh (peer reviewer) has no disclosures to report
Maria Glukhovsky, PharmD (planning committee) has no disclosures to report.
Jan Perez (planning committee) has no disclosures to report.
Sharon Tordoff (planning committee) has no disclosures to report.
Disclosures were obtained from the CME Outfitters, LLC staff: No disclosures to report.
Faculty of this CE activity may include discussions of products or devices that are not currently labeled for use by the FDA. The faculty have been informed of their responsibility to disclose to the audience if they will be discussing off-label or investigational uses (any uses not approved by the FDA) of products or devices.
Questions about this activity? Call us at 877.CME.PROS (877.263.7767).